Tags: Clinical Trials

announcements

Dr. Roberta Diaz Brinton Wins Alzheimer's Drug Discovery Foundation's Melvin R. Goodes Prize

Dr. Brinton has pioneered a promising neurogenesis therapy for Alzheimer’s disease.

announcements

18th Annual Conference on Alzheimer's Drug Discovery Showcases Non-Amyloid Research

Nearly 200 academic and industry researchers came together to share updates on innovative preclinical and clinical-stage Alzheimer’s disease research at the 18th Annual Conference on Alzheimer's Drug Discovery.

blog

Driving Innovation in Alzheimer's Therapies

At our 18th Annual Conference on Alzheimer’s Drug Discovery in Jersey City, the impact of our approach will take center stage.

blog

Inflammation, The Driver of Alzheimer's Disease?

A growing body of evidence suggests that inflammation in the brain is implicated in the development of Alzheimer's.

announcements

Latest Funding Includes Support for Innovative Clinical Trial

The ADDF announces four new grants, including support for an innovative clinical trial, two novel drug programs, and a biomarker for CTE.

announcements

2016 Annual Report Released

The 2016 Annual Report, titled “From Idea to Impact,” highlights the enormous progress the ADDF has made toward finding effective treatments for Alzheimer’s disease.

blog

Clinical Trials Inspiring Hope

Since 1998, the ADDF has invested over $100 million in the best ideas to cure Alzheimer's. We are seeing the impact of our efforts, with many promising drugs in clinical trials on the way.

blog

Trial of First Broad-Spectrum Drug for Neurodegeneration Seeking Volunteers

ADDF grantee Dr. Raymond Scott Turner is recruiting patients for a phase 2 trial of nilotinib—a leukemia drug being tested for treating Alzheimer’s.

announcements

ADDF Invests $300,000 to Support Phase 2 Clinical Trial of Epigenetic Therapy

A new investment of $300,000 in Oryzon Genomics continues our support of its groundbreaking epigenetic drug ORY-2001.

announcements

ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimer's and FTD

A team of scientists from the Medical Research Council (MRC) in the UK have found two drugs, which block brain cell death and prevent neurodegeneration in preclinical studies. Their findings were published today in Brain.